🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for AIS

Personalized Prevention and Treatment Strategies for Adolescent Idiopathic Scoliosis Via a Comprehensive Health Management Platform NCT06314594NA1 site📍 Hangzhou Hangzhou Medical College · Tests: Conventional treatment, intervention treatment Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis NCT03935295Phase 41 site📍 Baltimore Johns Hopkins University · Tests: AbobotulinumtoxinA, Placebos, Custom Thoracolumbosacral Orthosis Determining Best Indications for Bracing for Adolescent Idiopathic Scoliosis NCT04117334n/a2 sites📍 Hong Kong📍 Hong Kong The University of Hong Kong · Tests: Bracing ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 NCT06320431Phase 324 sites📍 Sydney📍 Sydney📍 Melbourne University of Calgary · Tests: Tenecteplase Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke NCT07003386Phase 2, Phase 31 site📍 Shanghai Shanghai Yueyang Integrated Medicine Hospital · Tests: Galantamine, Standard treatment for acute ischemic stroke Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis NCT06992622n/a1 site📍 Wenzhou Second Affiliated Hospital of Wenzhou Medical University Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS) NCT06696703NA1 site📍 Harbin First Affiliated Hospital of Harbin Medical University · Tests: Human urinary kininogenase(HUK), Placebo Frontal/Axial and Self Body Image In Scoliosis NCT07166328n/a1 site📍 New Cairo Al Hayah University In Cairo · Tests: BACKSCNR , measure the deviations of frontal and axial back asymmetry in AIS Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients NCT06733246NA1 site📍 Heidelberg Ceretrieve Ltd. · Tests: Aspiration 0 Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer NCT07260435Phase 326 sites📍 Alkmaar📍 Amersfoort📍 Amsterdam Nick Beije · Tests: ADT plus only 12 months of ARPI, ADT plus continued ARPI Acute Ischemic Stroke in Patients With Active Cancer NCT07819526n/a1 site📍 Suita Osaka University Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response NCT06592924Phase 3395 sites📍 Anchorage📍 Anchorage📍 Anchorage Canadian Cancer Trials Group · Tests: Abiraterone, Enzalutamide, Apalutamide, Darolutamide (BAY 1841788), Docetaxel FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions NCT07749170n/a5 sites📍 Englewood📍 New Haven📍 Lexington Penumbra Inc. · Tests: Endovascular Thrombectomy, Medical Management Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) NCT05404139Phase 22 sites📍 Toronto📍 Toronto University Health Network, Toronto · Tests: Abiraterone, Standard of Care SBRT and ADT, Atorvastatin A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset. NCT07520565Phase 39 sites📍 Hengshui📍 Daqing📍 Nanyang Biocells (Beijing) Biotech Co.,Ltd · Tests: BXOS110, placebo Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer NCT07140900Phase 116 sites📍 San Francisco📍 Boston📍 Minneapolis Amgen · Tests: Xaluritamig, Darolutamide, Abiraterone Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma NCT06348264Phase 22 sites📍 Beijing📍 Beijing Peking University First Hospital · Tests: Rezvilutamide, Leuprolide Acetate Trials of Intelligent Nighttime Brace With Smart Padding to Treat of Adolescent Idiopathic Scoliosis NCT05790031NA1 site📍 Hong Kong The Hong Kong Polytechnic University · Tests: Intelligent Nighttime Brace Safety and Efficacy of J147 in Acute Ischemic Stroke NCT07430917Phase 25 sites📍 Long Beach📍 Rockford📍 Albany Abrexa Pharmaceuticals, Inc. · Tests: J147 Emulsion for Injection, Placebo 3D, Dynamic and Mechanically-informed Decision Making in AIS NCT04761549NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Adolescent Idiopathic Scoliosis Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer NCT04947189Phase 1, Phase 21 site📍 Darlinghurst St Vincent's Hospital, Sydney · Tests: Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel UK SMA Patient Registry NCT04292574n/a1 site📍 Newcastle upon Tyne Newcastle University · Tests: Patient Registry A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy NCT06169046Phase 21 site📍 Padova Gianni Soraru · Tests: Clenbuterol, Placebo Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke NCT07174505NA2 sites📍 Budapest📍 Barcelona Anaconda Biomed S.L. · Tests: Mechanical Thrombectomy using the CONDA Stent Retriever Dynamic Pressure Monitoring System for Orthotic Treatment of Scoliosis NCT03716843n/a1 site📍 Tsim Sha Tsui The Hong Kong Polytechnic University · Tests: Pressure monitoring system One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy NCT07052045NA2 sites📍 Nuremberg📍 Basel Prof. Dr. Jan Liman · Tests: One Stop Management, Usual care management Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis NCT02315729n/a1 site📍 Denver University of Colorado, Denver Advanced SPinal Innovations With Robotics and Enabling Technology Registry NCT05071144n/a10 sites📍 Los Angeles📍 Aurora📍 Atlanta Boston Children's Hospital Support System Design for Adolescent Scoliosis Orthosis Wear NCT07574229NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Digital Support System for AIS Orthosis Wear, Conventional Treatment Control Group Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI NCT04812431Phase 1, Phase 22 sites📍 Suwon📍 Seoul S.Biomedics Co., Ltd. · Tests: Neural precursor cells derived from human embryonic stem cell line
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy